IRIS
Grandi, Guido
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.939
AS - Asia 2.010
EU - Europa 1.298
SA - Sud America 642
AF - Africa 43
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.944
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.878
SG - Singapore 867
BR - Brasile 522
CN - Cina 493
VN - Vietnam 354
RU - Federazione Russa 287
IT - Italia 241
SE - Svezia 157
FI - Finlandia 131
GB - Regno Unito 106
LV - Lettonia 91
DE - Germania 78
HK - Hong Kong 65
BG - Bulgaria 60
ID - Indonesia 56
TR - Turchia 56
AR - Argentina 49
BD - Bangladesh 28
EC - Ecuador 27
UA - Ucraina 27
MX - Messico 25
CA - Canada 23
FR - Francia 20
IN - India 20
AT - Austria 18
IQ - Iraq 18
ZA - Sudafrica 18
PL - Polonia 15
CO - Colombia 14
ES - Italia 13
CL - Cile 11
NL - Olanda 11
AU - Australia 9
CZ - Repubblica Ceca 9
JP - Giappone 9
PE - Perù 7
TN - Tunisia 7
PY - Paraguay 6
SK - Slovacchia (Repubblica Slovacca) 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
IE - Irlanda 5
PT - Portogallo 5
BE - Belgio 4
IL - Israele 4
PK - Pakistan 4
RO - Romania 4
VE - Venezuela 4
AM - Armenia 3
CH - Svizzera 3
DZ - Algeria 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
BW - Botswana 2
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
IR - Iran 2
KG - Kirghizistan 2
PA - Panama 2
PR - Porto Rico 2
SA - Arabia Saudita 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
MQ - Martinica 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 9.944
Salva come PNG Salva come JPEG
Città #
Fairfield 852
Ashburn 536
Singapore 536
Chandler 494
Woodbridge 390
Seattle 372
Houston 319
Wilmington 315
Cambridge 309
Santa Clara 201
Ann Arbor 178
Dallas 175
Columbus 167
Princeton 164
San Mateo 151
Jacksonville 150
Beijing 141
Moscow 125
Ho Chi Minh City 95
Riga 91
Dong Ket 90
Hangzhou 69
Los Angeles 66
Hong Kong 64
Helsinki 58
New York 57
Sofia 57
San Diego 55
Dearborn 53
Izmir 51
Trento 48
Hanoi 47
São Paulo 44
Jakarta 39
Phoenix 33
San Paolo di Civitate 33
Buffalo 29
Chicago 28
Council Bluffs 25
Como 24
Munich 24
London 22
Rio de Janeiro 19
Boardman 17
Norwalk 16
Altamura 15
Guangzhou 14
Hefei 14
Johannesburg 12
Nuremberg 12
Warsaw 12
Da Nang 11
Biên Hòa 10
Montreal 10
Redondo Beach 10
Rome 10
Brasília 9
Brooklyn 9
Nanjing 9
Quito 9
Salt Lake City 9
Baghdad 8
Belo Horizonte 8
Brno 8
Chennai 8
Des Moines 8
Fortaleza 8
Fremont 8
Haiphong 8
Orem 8
Schio 8
Shanghai 8
Stockholm 8
Tavagnacco 8
Tokyo 8
Toronto 8
Turku 8
Düsseldorf 7
Guarulhos 7
Mexico City 7
Naples 7
Thái Bình 7
Vienna 7
Boston 6
Bratislava 6
Denver 6
Hải Dương 6
Porto Alegre 6
Ribeirão Preto 6
Riva Del Garda 6
San Jose 6
Sydney 6
Tashkent 6
Xi'an 6
Andover 5
Campinas 5
Caxias do Sul 5
Changsha 5
Duque de Caxias 5
Frankfurt am Main 5
Totale 7.270
Salva come PNG Salva come JPEG
Nome #
Protectome analysis: A new selective bioinformatics tool for bacterial vaccine candidate discovery 227
Prochymosin expression in Bacillus subtilis 217
Structure of the type IX Group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII 209
Vaccination with a FAT1-derived B cell epitope combined with tumor-specific B and T cell epitopes elicits additive protection in cancer mouse models 207
Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus 196
Streptococcus agalactiae capsule polymer length and attachment is determined by the proteins CpsABCD 181
Some Gram-negative lipoproteins keep their surface topology when transplanted from one species to another and deliver foreign polypeptides to the bacterial surface 180
The human pathogen Streptococcus pyogenes releases lipoproteins as lipoprotein-rich membrane vesicles 173
Whole-genome epidemiology, characterisation, and phylogenetic reconstruction of Staphylococcus aureus strains in a paediatric hospital 172
Analysis of two-component systems in group B streptococcus shows that RgfAC and the novel FspSR modulate virulence and bacterial fitness 169
Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models 166
Auto-assembling detoxified staphylococcus aureus alpha-hemolysin mimicking the wild-type cytolytic toxin 166
Synergistic protective activity of tumor-specific epitopes engineered in bacterial outer membrane vesicles 165
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine 164
CD81 extracellular domain 3D structure: Insight into the tetraspanin superfamily structural motifs 163
Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting 158
One dose of staphylococcus aureus 4C-staph vaccine formulated with a novel TLR7-dependent adjuvant rapidly protects mice through antibodies, effector CD4+ T Cells, and IL-17A 157
Understanding the Molecular Determinants Driving the Immunological Specificity of the Protective Pilus 2a Backbone Protein of Group B Streptococcus 155
Vaccinology: The art of putting together the right ingredients 152
Targeted amino acid substitutions impair streptolysin O toxicity and group a Streptococcus virulence 150
Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer 148
New insights into the role of the glutamic acid of the E-box motif in group B Streptococcus pilus 2a assembly. 143
Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli 143
A structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections. 142
FAT1: A potential target for monoclonal antibody therapy in colon cancer 142
Approach to discover T and B cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. 137
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform 135
Structural Basis for Group B Streptococcus Pilus 1 Sortases C Regulation and Specificity 134
Cloning and nucleotide sequence of the isoamylase gene from a strain of Pseudomonas sp 133
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population 133
Structural vaccinology starts to deliver 128
ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer 126
MF59- and Al(OH)3-adjuvanted Staphylococcus aureus (4C-Staph) vaccines induce sustained protective humoral and cellular immune responses, with a critical role for effector CD4 T cells at low antibody titers 124
Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings 123
A rapid and versatile site-directed method of mutagenesis for double-stranded plasmid DNA 123
SpyAD, a moonlighting protein of group A Streptococcus contributing to bacterial division and host cell adhesion 119
Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. 117
Engineering outer membrane vesicles 116
Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro 115
Three-dimensional human skin models to understand Staphylococcus aureus skin colonization and infection 115
The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera 114
Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP 113
Rational antibacterial vaccine design through genomic technologies 112
Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes 111
Antibacterial vaccine design using genomics and proteomics 111
A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins. 110
Multiple Stepwise Gene Knockout Using CRISPR/Cas9 in Escherichia coli 110
Antibody-mediated immunity induced by engineered Escherichia coli Outer Membrane Vesicles (OMVs) carrying heterologous antigens in their lumen 109
Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women. 108
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow 107
Four-component Staphylococcus aureus vaccine 4C-staph enhances fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice 107
Sortase A substrate specificity in GBS pilus 2a cell wall anchoring. 104
Sequence and analysis of the genetic locus responsible for surfactin synthesis in Bacillus subtilis 101
Crystal structures of the components of the Staphylococcus aureus leukotoxin ED 99
Streptococcus pyogenes SpyCEP influences host-pathogen interactions during infection in a murine air pouch model 93
Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice. 92
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines 90
Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells 85
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 85
Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case. 85
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 84
Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP 84
Immobilized metal-ion affinity chromatography of human growth hormone 84
The impact of genomics in vaccine discovery: achievements and lessons 84
Recombinant and truncated tetanus neurotoxin light chain: Cloning, expression, purification, and proteolytic activity 84
A Bacillus subtilis large ORF coding for a polypeptide highly similar to polyketide synthases. 82
Structural vaccinology starts to deliver 81
TCTN2: A novel tumor marker with oncogenic properties 79
Structural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2 79
Cumulative stabilizing effects of hydrophobic interactions on the surface of the neutral protease from Bacillus subtilis 78
The complete genome sequence of the gram-positive bacterium Bacillus subtilis 75
Gene expression profile in Neisseria meningitidis and Neisseria lactamica upon host-cell contact: from basic research to vaccine development 75
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles 74
Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen. 74
Surface Interactome in Streptococcus pyogenes. 71
Identification of vaccine candidates against serogroup B meningococcus genome sequencing. 67
Characterization of the locus encoding the [Ni-Fe] sulfhydrogenase from the archaeon Pyrococcus furiosus: evidence for a relationship to bacterial sulfite reductases. 66
R-factor mediated suppression of the galacto-sensitive phenotype of E.coli K12 galE mutants. 64
tructure analysis and site-directed mutagenesis of defined key residues and motives for pilus-related sortase C1 in group B Streptococcus. 62
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells 60
Structure, dynamics and immunogenicity of a catalytically inactive CXC chemokine-degrading protease SpyCEP from Streptococcus pyogenes 58
Model building of a thermolysin-like protease by mutagenesis. 57
Mining the bacterial unknown proteome: Identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureus 57
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis 55
Purification of recombinant human growth hormone by isoelectric focusing in a multicompartment electrolyzer with Immobiline membranes. 54
Identification of novel iron-activated and -repressed fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B 53
Efficient conversion of 5-substituted hydantoins to D-amino acids using recombinant E. coli strains 48
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer 47
Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus 45
Grafting of a calcium binding loop of thermolysin to B. subtilis neutral protease. 43
Rheumatic immune-and nonimmune-related adverse events in phase 3 clinical trials assessing PD-(L)1 checkpoint inhibitors for lung cancer: A systematic review and meta-analysis 37
Totale 10.230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.574
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.574
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021880 0 0 0 0 0 152 157 109 57 112 97 196
2021/20221.081 57 149 18 99 28 42 34 219 59 96 118 162
2022/20231.018 150 154 23 134 89 156 10 80 108 8 57 49
2023/2024339 24 34 21 16 30 46 46 14 4 16 33 55
2024/20251.699 10 6 74 408 60 246 30 90 173 298 105 199
2025/20262.344 246 126 563 965 287 157 0 0 0 0 0 0
Totale 10.230